Spitalul Clinic CF nr.2 Bucuresti

Bucharest 011464

1 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Metastatic Breast Cancer

Studies at this site

• A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence — Recruiting now
• Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3) — Completed